Objectives: At present, there is no report on the application of Guy's stone (GS) score in minimally invasive percutaneous nephrolithotomy (MPCNL). We therefore investigate the clinical effect of MPCNL by using a patented irrigation and clearance system according to the GS. Methods: A total of 222 consecutive patients were divided into 2 groups that were treated with MPCNL using the patented system or standard PCNL using Electro Medical System (EMS) ultrasound/ballistic trajectory lithotripsy and clearance system, respectively (124 patients in patented system group, 98 patients in EMS system group). The stone complexity and severity of complications were stratified by GS and Modified Clavien grading system in this study, respectively. The success and complication rates between MPCNL and PCNL were compared. Results: The patented system group had a significantly higher success rate (GS3: 95 vs. 43% and GS4: 67 vs. 31%) and a significantly less complications rate (GS3: 12 vs. 27% and GS4: 21 vs. 46%) in GS3 and GS4 compared with the EMS system group. Also, the patented system had significant lower complication rates in Clavien grades II-IV than that of the EMS system. Conclusion: The MPCNL using the patented irrigation and clearance system was more efficient in dealing with renal stones of high complexity (GS3-4).

1.
Fernström I, Johansson B: Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 1976;10:257-259.
2.
Tiselius H, Alken P, Buck C, et al: Guidelines on Urolithiasis. European Association of Urology, 2014.
3.
Wang Y, Hou Y, Jiang F, Wang Y, Chen Q, Lu Z, Hu J, Wang X, Lu J, Wang C: Standard-tract combined with mini-tract in percutaneous nephrolithotomy for renal staghorn calculi. Urol Int 2014;92:422-426.
4.
Al-Kohlany KM, Shokeir AA, Mosbah A, Mohsen T, Shoma AM, Eraky I, El-Kenawy M, El-Kappany HA: Treatment of complete staghorn stones: a prospective randomized comparison of open surgery versus percutaneous nephrolithotomy. J Urol 2005;173:469-473.
5.
Yang Z, Song L, Xie D, Hu M, Peng Z, Liu T, Du C, Zhong J, Qing W, Guo S, Zhu L, Yao L, Huang J, Fan D, Ye Z: Comparative study of outcome in treating upper ureteral impacted stones using minimally invasive percutaneous nephrolithotomy with aid of patented system or transurethral ureteroscopy. Urology 2012;80:1192-1197.
6.
Song L, Chen Z, Liu T, Zhong J, Qin W, Guo S, Peng Z, Hu M, Du C, Zhu L, Yao L, Yang Z, Huang J, Xie D: The application of a patented system to minimally invasive percutaneous nephrolithotomy. J Endourol 2011;25:1281-1286.
7.
Thomas K, Smith NC, Hegarty N, Glass JM: The Guy's stone score - grading the complexity of percutaneous nephrolithotomy procedures. Urology 2011;78:277-281.
8.
Wang K, Zhang P, Xu X, Fan M: Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a meta-analysis. Urol Int 2015;95:15-25.
9.
Fan D, Song L, Xie D, Hu M, Peng Z, Liao X, Liu T, Du C, Zhu L, Yao L, Huang J, Yang Z, Guo S, Qin W, Zhong J, Ye Z: A comparison of supracostal and infracostal access approaches in treating renal and upper ureteral stones using MPCNL with the aid of a patented system. BMC Urol 2015;15:102.
10.
Tefekli A, Ali Karadag M, Tepeler K, Sari E, Berberoglu Y, Baykal M, Sarilar O, Muslumanoglu AY: Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 2008;53:184-190.
11.
Skolarikos A, Papatsoris AG: Diagnosis and management of postpercutaneous nephrolithotomy residual stone fragments. J Endourol 2009;23:1751-1755.
12.
Sfoungaristos S, Lorber A, Gofrit ON, Yutkin V, Landau EH, Pode D, Duvdevani M: External validation and predictive accuracy assessment of Guy's stone score as a preoperative tool for estimating percutaneous nephrolithotomy outcomes. J Endourol 2015;29:1131-1135.
13.
Zeng G, Zhao Z, Wan S, Mai Z, Wu W, Zhong W, Yuan J: Minimally invasive percutaneous nephrolithotomy for simple and complex renal caliceal stones: a comparative analysis of more than 10,000 cases. J Endourol 2013;27:1203-1208.
14.
Vicentini FC, Marchini GS, Mazzucchi E, Claro JF, Srougi M: Utility of the Guy's stone score based on computed tomographic scan findings for predicting percutaneous nephrolithotomy outcomes. Urology 2014;83:1248-1253.
15.
Patel SR, Haleblian GE, Pareek G: Percutaneous nephrolithotomy can be safely performed in the high-risk patient. Urology 2010;75:51-55.
16.
Michel MS, Trojan L, Rassweiler JJ: Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906.
17.
Torrecilla C, Vicéns-Morton AJ, Meza IA, Colom S, Etcheverry B, Vila H, Franco E Complications of percutaneous nephrolithotomy in the prone position according with modified Clavien-Dindo grading system. Actas Urol Esp 2015;39:169-174.
18.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
19.
Morgan M, Smith N, Thomas K, Murphy DG: Is Clavien the new standard for reporting urological complications? BJU Int 2009;104:434-436.
20.
Cheng F, Yu W, Zhang X, Yang S, Xia Y, Ruan Y: Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 2010;24:1579-1582.
21.
Li X, He Z, Wu K, Li SK, Zeng G, Yuan J, He Y, Lei M: Chinese minimally invasive percutaneous nephrolithotomy: the Guangzhou experience. J Endourol 2009;23:1693-1697.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.